Skip to main content
Top

16-06-2017 | Colorectal cancer | Book chapter | Article

6. PET/CT in Colorectal Cancer

Author: Yong Du, M.B.B.S., M.Sc., Ph.D., F.R.C.P.

Publisher: Springer International Publishing

Abstract

Introduction
Literature
1.
DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.CrossRefPubMed
2.
Schmoll HJ, Van CE, Stein A, et al. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol. 2012;23:2479–516.CrossRefPubMed
3.
Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–17.CrossRefPubMed
4.
Berger KL, Nicholson SA, Dehdashti F, et al. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174:1005–8.CrossRefPubMed
5.
Brush J, Boyd K, Chappell F, et al. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technol Assess. 2011;15:1–192.CrossRefPubMedPubMedCentral
6.
Lastoria S, Piccirillo MC, Caraco C, et al. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab. J Nucl Med. 2013;54:2062–9.CrossRefPubMed
7.
Maizlin ZV, Brown JA, So G, et al. Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer? Dis Colon rectum. 2010;53:308–14.CrossRefPubMed
8.
Perez RO, Habr-Gama A, Gama-Rodrigues J, et al. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683). Cancer. 2012;118:3501–11.CrossRefPubMed
9.
Siriwardena AK, Mason JM, Mullamitha S, et al. Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol. 2014;11:446–59.CrossRefPubMed
10.
Stein A, Hiemer S, Schmoll HJ. Adjuvant therapy for early colon cancer: current status. Drugs. 2011;71:2257–75.CrossRefPubMed
11.
Tagliabue L. The emerging role of FDG PET/CT in rectal cancer management: is it time to use the technique for early prognostication? Eur J Nucl Med Mol Imaging. 2013;40:652–6.CrossRefPubMed